KRTAP9-3
gene geneOn this page
Also known as KAP9.3
Summary
KRTAP9-3 (keratin associated protein 9-3, HGNC:16927) is a protein-coding gene on chromosome 17q21.2, encoding Keratin-associated protein 9-3 (Q9BYQ3). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….
This protein is a member of the keratin-associated protein (KAP) family. The KAP proteins form a matrix of keratin intermediate filaments which contribute to the structure of hair fibers. KAP family members appear to have unique, family-specific amino- and carboxyl-terminal regions and are subdivided into three multi-gene families according to amino acid composition: the high sulfur, the ultrahigh sulfur, and the high tyrosine/glycine KAPs. This protein is a member of the ultrahigh sulfur KAP family and the gene is localized to a cluster of KAPs at 17q12-q21.
Source: NCBI Gene 83900 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 47 total
- MANE Select transcript:
NM_031962
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16927 |
| Approved symbol | KRTAP9-3 |
| Name | keratin associated protein 9-3 |
| Location | 17q21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KAP9.3 |
| Ensembl gene | ENSG00000204873 |
| Ensembl biotype | protein_coding |
| Entrez | 83900 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000411528
RefSeq mRNA: 1 — MANE Select: NM_031962
NM_031962
CCDS: CCDS11385
Canonical transcript exons
ENST00000411528 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001474938 | 41232449 | 41233454 |
Expression profiles
Bgee: expression breadth broad, 24 present calls, max score 41.54.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0312 / max 32.8238, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 160818 | 0.0312 | 3 |
Top tissues by expression
99 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skin of abdomen | UBERON:0001416 | 41.54 | gold quality |
| zone of skin | UBERON:0000014 | 39.48 | gold quality |
| skin of leg | UBERON:0001511 | 38.15 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| sural nerve | UBERON:0015488 | 36.76 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| right lung | UBERON:0002167 | 35.49 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| muscle of leg | UBERON:0001383 | 29.60 | gold quality |
| gastrocnemius | UBERON:0001388 | 29.43 | gold quality |
| blood | UBERON:0000178 | 29.38 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.23 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| monocyte | CL:0000576 | 27.96 | silver quality |
| leukocyte | CL:0000738 | 27.93 | silver quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| urinary bladder | UBERON:0001255 | 25.72 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
37 targeting KRTAP9-3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-3605-5P | 99.96 | 67.12 | 932 |
| HSA-MIR-16-5P | 99.90 | 72.80 | 2780 |
| HSA-MIR-518A-5P | 99.70 | 69.01 | 2209 |
| HSA-MIR-527 | 99.70 | 69.01 | 2209 |
| HSA-MIR-494-3P | 99.70 | 71.45 | 2795 |
| HSA-MIR-6832-5P | 99.58 | 64.82 | 1132 |
| HSA-MIR-4761-5P | 99.51 | 66.69 | 804 |
| HSA-MIR-186-3P | 99.51 | 66.24 | 1685 |
| HSA-MIR-3123 | 99.47 | 67.15 | 2693 |
| HSA-MIR-548B-3P | 99.38 | 67.26 | 1000 |
| HSA-MIR-6882-5P | 99.35 | 71.13 | 1206 |
| HSA-MIR-892C-5P | 99.16 | 70.56 | 2116 |
| HSA-MIR-3160-3P | 99.07 | 64.78 | 955 |
| HSA-MIR-922 | 99.02 | 67.23 | 1838 |
| HSA-MIR-3619-5P | 99.00 | 68.87 | 2308 |
| HSA-MIR-6770-5P | 98.97 | 66.76 | 1853 |
| HSA-MIR-3145-3P | 98.85 | 69.07 | 2031 |
| HSA-MIR-214-3P | 98.71 | 68.12 | 2128 |
| HSA-MIR-761 | 98.71 | 68.07 | 2051 |
| HSA-MIR-6796-3P | 98.68 | 65.49 | 689 |
| HSA-MIR-6728-3P | 98.63 | 67.63 | 1534 |
| HSA-MIR-3928-5P | 98.50 | 67.48 | 980 |
| HSA-MIR-6806-3P | 98.50 | 67.31 | 980 |
| HSA-MIR-6873-5P | 98.45 | 66.14 | 1417 |
| HSA-MIR-302F | 98.44 | 69.02 | 1776 |
| HSA-MIR-1262 | 98.17 | 66.52 | 757 |
| HSA-MIR-4701-3P | 98.17 | 66.25 | 788 |
| HSA-MIR-6736-5P | 98.17 | 66.43 | 760 |
Cross-species orthologs
0 orthologs
Paralogs (47): KRTAP4-4 (ENSG00000171396), KRTAP9-7 (ENSG00000180386), KRTAP5-5 (ENSG00000185940), KRTAP12-1 (ENSG00000187175), KRTAP9-8 (ENSG00000187272), KRTAP10-8 (ENSG00000187766), KRTAP10-6 (ENSG00000188155), KRTAP1-1 (ENSG00000188581), KRTAP10-12 (ENSG00000189169), KRTAP4-3 (ENSG00000196156), KRTAP9-9 (ENSG00000198083), KRTAP4-6 (ENSG00000198090), KRTAP4-5 (ENSG00000198271), KRTAP4-1 (ENSG00000198443), KRTAP4-8 (ENSG00000204880), KRTAP1-4 (ENSG00000204887), KRTAP12-3 (ENSG00000205439), KRTAP10-2 (ENSG00000205445), KRTAP5-6 (ENSG00000205864), KRTAP5-2 (ENSG00000205867), KRTAP16-1 (ENSG00000212657), KRTAP9-6 (ENSG00000212659), KRTAP4-11 (ENSG00000212721), KRTAP4-9 (ENSG00000212722), KRTAP2-3 (ENSG00000212724), KRTAP2-1 (ENSG00000212725), KRTAP10-3 (ENSG00000212935), KRTAP4-12 (ENSG00000213416), KRTAP2-4 (ENSG00000213417), KRTAP2-2 (ENSG00000214518), KRTAP10-4 (ENSG00000215454), KRTAP10-1 (ENSG00000215455), KRTAP10-9 (ENSG00000221837), KRTAP1-5 (ENSG00000221852), KRTAP10-10 (ENSG00000221859), KRTAP12-2 (ENSG00000221864), KRTAP1-3 (ENSG00000221880), KRTAP9-2 (ENSG00000239886), KRTAP9-1 (ENSG00000240542), KRTAP4-7 (ENSG00000240871)
Protein
Protein identifiers
Keratin-associated protein 9-3 — Q9BYQ3 (reviewed: Q9BYQ3)
Alternative names: Keratin-associated protein 9.3, Ultrahigh sulfur keratin-associated protein 9.3
All UniProt accessions (1): Q9BYQ3
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Similarity. Belongs to the KRTAP type 9 family.
RefSeq proteins (1): NP_114168* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002494 | KAP | Family |
Pfam: PF13885
UniProt features (18 total): repeat 16, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BYQ3-F1 | 36.86 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 20 (showing top):
GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_KERATIN_FILAMENT, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, REACTOME_KERATINIZATION, GOCC_SUPRAMOLECULAR_POLYMER, MIR3662, MIR494_3P, MIR892C_5P, MIR518A_5P_MIR527, MIR6770_5P, MIR6806_3P, MIR3928_5P, MIR3605_5P, MIR127_5P
GO Biological Process (0):
GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (3): cytosol (GO:0005829), keratin filament (GO:0045095), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein binding | 1 |
| binding | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
248 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP9-3 | KRTAP3-1 | Q9BYR8 | 587 |
| KRTAP9-3 | KRTAP13-3 | Q3SY46 | 544 |
| KRTAP9-3 | KRTAP17-1 | Q9BYP8 | 507 |
| KRTAP9-3 | KRTAP3-3 | Q9BYR6 | 467 |
| KRTAP9-3 | KRT33B | Q14525 | 431 |
| KRTAP9-3 | KRT83 | P78385 | 378 |
| KRTAP9-3 | KRT27 | Q7Z3Y8 | 369 |
| KRTAP9-3 | KRT86 | P78387 | 369 |
| KRTAP9-3 | KRT34 | O76011 | 359 |
| KRTAP9-3 | KRT71 | Q3SY84 | 353 |
| KRTAP9-3 | KRT31 | Q15323 | 324 |
| KRTAP9-3 | HID1 | Q8IV36 | 300 |
| KRTAP9-3 | FAM234B | A2RU67 | 250 |
| KRTAP9-3 | SRARP | Q8NEQ6 | 246 |
| KRTAP9-3 | ATOSA | Q32MH5 | 223 |
IntAct
431 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CDK12 | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CDC20 | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| NR1D2 | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF414 | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KRTAP9-3 | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| LCE2A | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| NTM | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| VASN | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| LCE3C | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CHRNG | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| WNT11 | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KRTAP9-3 | KRTAP5-9 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KRTAP9-3 | GLRX3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KRTAP9-3 | ATN1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KRTAP9-3 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KRTAP9-3 | ADAMTSL4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FBXW5 | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KRTAP5-3 | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF497 | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SLC25A18 | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CCER1 | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MAPKBP1 | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KRTAP9-3 | KRTAP10-5 | psi-mi:“MI:0915”(physical association) | 0.000 |
| DOCK2 | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PRKAB2 | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CRCT1 | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KRTAP10-10 | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| LCE1A | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KRTAP9-3 | NOTCH2NLC | psi-mi:“MI:0915”(physical association) | 0.000 |
| KRTAP9-3 | RGS20 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (140): KRTAP9-3 (Affinity Capture-MS), KRTAP9-3 (Affinity Capture-MS), KRTAP9-3 (Two-hybrid), KRTAP9-3 (Two-hybrid), KRTAP9-3 (Two-hybrid), KRTAP9-3 (Two-hybrid), KRTAP9-3 (Two-hybrid), KRTAP9-3 (Two-hybrid), KRTAP9-3 (Two-hybrid), KRTAP9-3 (Two-hybrid), KRTAP9-3 (Two-hybrid), KRTAP9-3 (Two-hybrid), KRTAP9-3 (Two-hybrid), KRTAP9-3 (Two-hybrid), KRTAP9-3 (Two-hybrid)
ESM2 similar proteins: A5A6P5, A6QP35, A8MTY7, A8MVA2, A8MXZ3, O75690, P02438, P02441, P02442, P02443, P08131, P0C7H8, P26371, P59990, P59991, P60014, P60331, P60368, P60369, P60370, P60371, P60372, P60409, P60410, P60411, P60412, P60413, Q05B44, Q07627, Q3V2C1, Q6L8G4, Q6L8G8, Q6L8G9, Q6L8H2, Q701N4, Q8IUG1, Q9BQ66, Q9BYP9, Q9BYQ0, Q9BYQ2
Diamond homologs: A5A6P5, Q9BYP9, Q9BYQ0, Q9BYQ2, Q9BYQ3, Q9BYQ4, A8MTY7, A8MVA2
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 120 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 44 | 28.2× | 1e-52 |
| Formation of the cornified envelope | 18 | 18.2× | 2e-16 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| keratinization | 17 | 43.7× | 3e-21 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
47 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 39 |
| Likely benign | 8 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
295 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:41233277:G:GT | donor_gain | 0.7900 |
| 17:41233181:C:G | acceptor_gain | 0.7500 |
| 17:41233112:T:G | acceptor_gain | 0.7400 |
| 17:41233180:A:AG | acceptor_gain | 0.7300 |
| 17:41233186:T:TA | acceptor_gain | 0.7200 |
| 17:41233187:G:A | acceptor_gain | 0.6700 |
| 17:41232729:T:TA | donor_gain | 0.6500 |
| 17:41232730:A:AA | donor_gain | 0.6500 |
| 17:41233373:AC:A | acceptor_gain | 0.6500 |
| 17:41233180:ACCTT:A | acceptor_gain | 0.6400 |
| 17:41232775:C:A | donor_gain | 0.6300 |
| 17:41232947:G:GG | donor_gain | 0.6300 |
| 17:41232924:G:GT | donor_gain | 0.6200 |
| 17:41232843:T:TA | acceptor_gain | 0.6100 |
| 17:41233201:C:G | donor_gain | 0.6100 |
| 17:41233141:G:T | donor_gain | 0.6000 |
| 17:41233272:C:G | donor_gain | 0.6000 |
| 17:41233278:A:T | donor_gain | 0.6000 |
| 17:41233373:A:AG | acceptor_gain | 0.5900 |
| 17:41233374:C:G | acceptor_gain | 0.5900 |
| 17:41233236:C:G | donor_gain | 0.5800 |
| 17:41233374:C:CA | acceptor_gain | 0.5800 |
| 17:41232668:GCT:G | donor_gain | 0.5600 |
| 17:41232670:T:G | donor_gain | 0.5600 |
| 17:41232774:TCA:T | donor_gain | 0.5600 |
| 17:41232601:C:A | donor_gain | 0.5500 |
| 17:41233140:G:GT | donor_gain | 0.5500 |
| 17:41232671:G:GG | donor_gain | 0.5400 |
| 17:41232909:G:GT | donor_gain | 0.5400 |
| 17:41233220:G:GT | donor_gain | 0.5400 |
AlphaMissense
1053 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:41232810:A:C | R103S | 0.658 |
| 17:41232810:A:T | R103S | 0.658 |
| 17:41232804:C:G | C101W | 0.622 |
| 17:41232934:T:C | F145L | 0.616 |
| 17:41232936:C:A | F145L | 0.616 |
| 17:41232936:C:G | F145L | 0.616 |
| 17:41232814:T:C | C105R | 0.612 |
| 17:41232847:T:C | C116R | 0.579 |
dbSNP variants (sampled 300 via entrez): RS1001064896 (17:41232354 G>A,T), RS1002502036 (17:41231328 A>G), RS1004157836 (17:41231309 T>C), RS1004210358 (17:41231103 G>A), RS1004491104 (17:41232549 C>A,G), RS1005480270 (17:41231596 ACTT>A,ACTTCTT), RS1006161654 (17:41233456 A>G), RS1006215762 (17:41233193 T>C), RS1007808396 (17:41233716 C>A,G), RS1008285857 (17:41230477 T>C), RS1008401683 (17:41230716 T>A), RS1008619462 (17:41231635 C>T), RS1010469165 (17:41230668 A>G), RS1010797738 (17:41231868 A>G,T), RS1012400222 (17:41232742 T>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| hydroxyhydroquinone | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.